Skip to main content

Peer Review reports

From: COVID-19 monoclonal antibody treatment impact on symptoms and post-COVID conditions among high-risk patients at a Federally Qualified Health Center

Original Submission
20 Sep 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
21 Oct 2022 Reviewed Reviewer Report
23 Oct 2022 Reviewed Reviewer Report
18 Nov 2022 Author responded Author comments - Christian B. Ramers
Resubmission - Version 3
18 Nov 2022 Submitted Manuscript version 3
28 Nov 2022 Author responded Author comments - Christian B. Ramers
Resubmission - Version 4
28 Nov 2022 Submitted Manuscript version 4
8 Dec 2022 Reviewed Reviewer Report
5 Feb 2023 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
6 Feb 2023 Editorially accepted
22 Feb 2023 Article published 10.1186/s12879-023-08057-7

You can find further information about peer review here.

Back to article page